COMMENTARY on Lammers et al, Diagnosis of central disorders of hypersomnolence: Challenges in defining central disorders of hypersomnolence-Reference-Cited by-同舟云学术

COMMENTARY on Lammers et al, Diagnosis of central disorders of hypersomnolence: Challenges in defining central disorders of hypersomnolence

Published:2020-08 Issue: Volume:52 Page:101327
ISSN:1087-0792
Container-title:Sleep Medicine Reviews
language:en
Short-container-title:Sleep Medicine Reviews

Author:

Maski Kiran^ORCID,Mignot Emmanuel,Scammell Thomas E.

Funder

National Institutes of Health

Jazz Pharmaceuticals

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,Pulmonary and Respiratory Medicine

Reference10 articles.

1. International classification of sleep disorders - third edition (ICSD-3);American Academy of Sleep Medicine,2014

2. The MSLT is repeatable in narcolepsy type 1 but not narcolepsy type 2: a retrospective patient study;Ruoff;J Clin Sleep Med–JCSM–Off Pub Am Acad Sleep Med,2018

3. Test-retest reliability of the multiple sleep latency test in central disorders of hypersomnolence;Lopez;Sleep,2017

4. Diagnosis of central disorders of hypersomnolence: a reappraisal;Lammers;Sleep Med Rev,2020

5. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy;Ollila;Am J Hum Genet,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological options for narcolepsy: are they the way forward?;Expert Review of Neurotherapeutics;2023-08-29

2. Comparative polysomnography parameters between narcolepsy type 1/type 2 and idiopathic hypersomnia: A systematic review and meta-analysis;Sleep Medicine Reviews;2022-06

3. Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering;Neurology;2022-04-18

4. The growing toolkit for evaluation of central disorders of hypersomnolence;Sleep;2022-02-17

5. Polysomnographic nighttime features of narcolepsy: A systematic review and meta-analysis;Sleep Medicine Reviews;2021-08